Alliance for Cancer Gene Therapy (ACGT) is celebrating its anniversary with a Gala on Wednesday, April 19 at 6:30 p.m., at The Harvard Club of New York City. ACGT, founded by Greenwich residents Barbara and Edward Netter, is the nation’s only non-profit dedicated exclusively to cell and gene therapies for cancer.
Barbara Netter, ACGT’s honorary chairman of the Board and co-founder, will present the first-ever “Edward Netter Award for Business and Industry” to Dr. John Lahey, president of Quinnipiac University and an ACGT Board member since 2004. Gala speakers also include: ACGT research fellow Dr. Robert Vonderheide of the University of Pennsylvania, who will speak on the breakthroughs using immunotherapy for the treatment of solid cancers; and Doug Olson, one of the first three patients treated in the groundbreaking cancer immunotherapy CAR-T clinical trial developed by ACGT research fellow and Scientific Advisory Council member, Dr. Carl June.
Tickets for the ACGT Gala are $750 and are available at acgtfoundation.org/events or by emailing Barbara Gallagher, ACGT national director of philanthropy at bgallagher@acgtfoundation.org
